Skip to content

Member

Anja HAZEKAMP

The Left · Netherlands

Group
The Left
Country
Netherlands
Roll-call participation
50.3 %ⓘ of 620 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line
79.2 %ⓘ of 308 votes where the group had a line · The Left median 86.6 %
More facts (5)
National party
PvdD Partij voor de Dieren
In office
Since 16 Jul 2024
Against clear line
42 of 249 votesⓘ
Committees
AGRI (substitute), ENVI (vice-chair), PECH, SANT (substitute)
Member id
125023
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

50.3 %

312 of 620 final votes while in office

The Left median: 86.9 % (−36.6 pts)

Chamber median: 90.6 %

With majority line ⓘ

79.2 %

244 of 308 votes where their group had a line

The Left median: 86.6 % (−7.4 pts)

Against clear line ⓘ

16.9 %

42 of 249 votes where their group had a clear line

11 opposite (for ↔ against), 15 abstained against the line, 16 voted for or against when the line was to abstain

Abstention ⓘ

13.1 %

41 of 312 votes cast

Participation 50.3 % — The Left median 86.9 %, 47 members.ⓘ
Data as a table
Participation among the 47 members of the The Left with enough votes.
FigureParticipation
Anja HAZEKAMP50.3 %
The Left median86.9 %
Lowest in the group37.7 %
Highest in the group99.4 %
Members47
With majority line 79.2 % — The Left median 86.6 %, 47 members.ⓘ
Data as a table
With majority line among the 47 members of the The Left with enough votes.
FigureWith majority line
Anja HAZEKAMP79.2 %
The Left median86.6 %
Lowest in the group64.5 %
Highest in the group91.8 %
Members47
  • Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of The Left; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 928

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 46 — part 2 406 for, 214 against, 29 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 46 — part 1 470 for, 117 against, 63 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 3 334 for, 270 against, 34 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 2 327 for, 272 against, 42 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 45 — part 1 433 for, 153 against, 53 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on paragraph 44 349 for, 228 against, 79 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 43 — part 2 340 for, 285 against, 24 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 43 — part 1 358 for, 210 against, 81 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Separate vote on paragraph 41 362 for, 214 against, 75 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 24 — part 2 337 for, 303 against, 19 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 24 — part 1 532 for, 42 against, 82 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 21 — part 2 433 for, 135 against, 65 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 21 — part 1 548 for, 37 against, 60 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 8, adding text after paragraph 19 215 for, 294 against, 144 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 7, adding text after paragraph 19 278 for, 304 against, 69 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 3 399 for, 182 against, 72 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 2 299 for, 354 against, 6 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 18 — part 1 435 for, 197 against, 22 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 4 353 for, 224 against, 63 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 3 330 for, 256 against, 57 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 2 339 for, 302 against, 12 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 16 — part 1 539 for, 20 against, 88 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 3 388 for, 169 against, 88 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 2 472 for, 133 against, 45 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 8 — part 1 501 for, 61 against, 74 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Amendment 6, adding text after paragraph 6 194 for, 309 against, 145 abstainedPosition: Against Majority line: Against
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 6 — part 5 342 for, 280 against, 30 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 6 — part 4 601 for, 46 against, 9 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 3 — part 2 490 for, 141 against, 26 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Paragraph 3 — part 1 406 for, 200 against, 35 abstainedPosition: For Majority line: For
16 Sept 2026An EU cardiovascular diseases strategy Final vote on the motion for a resolutionAdopted 545 for, 47 against, 75 abstainedPosition: Against ≠ groupMajority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Final vote — text as a wholeAdopted 470 for, 129 against, 62 abstainedPosition: For Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 6, adding text after recital F 213 for, 426 against, 20 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 12, adding text after paragraph 64 218 for, 434 against, 4 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 11, adding text after paragraph 64 220 for, 432 against, 6 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 10, adding text after paragraph 64 175 for, 438 against, 50 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 9 to paragraph 64 205 for, 442 against, 10 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 8 to paragraph 56 216 for, 439 against, 8 abstainedPosition: Against Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Amendment 7 to paragraph 35 231 for, 426 against, 9 abstainedPosition: Against Majority line: Against
16 Sept 2026Nuclear decommissioning assistance programme of the Ignalina nuclear power plant in Lithuania for the period 2028-2034 Final votePassed 625 for, 20 against, 22 abstainedPosition: For Majority line: For
16 Sept 2026EU-Norway Agreement on the participation of Norway in GOVSATCOM and in the Union Secure Connectivity Programme Final vote on the draft Council decisionConsent given 612 for, 8 against, 16 abstainedPosition: For Majority line: For
16 Sept 2026Instrument for Nuclear Safety Cooperation 2028-2034 Final votePassed 600 for, 21 against, 48 abstainedPosition: For Majority line: For
16 Sept 2026EU-Iceland Agreement on the participation of Iceland in GOVSATCOM and in the Union Secure Connectivity Programme Final vote on the draft Council decisionConsent given 631 for, 7 against, 15 abstainedPosition: For Majority line: For
16 Sept 2026EU-Switzerland Agreement on the transfer of passenger name record (PNR) data for the prevention, detection, investigation and prosecution of terrorist offences and serious crime Final vote on the draft Council decisionConsent given 549 for, 75 against, 30 abstainedPosition: Against Majority line: Against
16 Sept 2026EU-UK Agreement regarding cooperation on the application of their respective competition laws Final vote on the draft Council decisionConsent given 640 for, 5 against, 26 abstainedPosition: For Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Final votePassed 496 for, 53 against, 125 abstainedPosition: For Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 86 to Article 9, paragraph 2 131 for, 532 against, 10 abstainedPosition: Against Majority line: Against
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 85, adding text after Article 8 138 for, 532 against, 4 abstainedPosition: Against Majority line: Against
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Amendment 84 to Article 4, after paragraph 1 168 for, 505 against, 4 abstainedPosition: Against Majority line: Against
16 Sept 2026Defence readiness and facilitating defence investments and conditions for the defence industry (Omnibus V) Final vote on the provisional agreementPassed 530 for, 125 against, 12 abstainedPosition: Against Majority line: Against

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 36 of 80 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within The Left

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Martin GÜNTHER The LeftGermany88 % of 1 603 shared87 %
Sebastian EVERDING Former memberThe LeftGermany87 % of 2 552 shared87 %
Jussi SARAMO The LeftFinland86 % of 3 028 shared87 %
Ilaria SALIS The LeftItaly86 % of 2 448 shared87 %
Per CLAUSEN The LeftDenmark86 % of 2 755 shared87 %
Younous OMARJEE The LeftFrance86 % of 2 441 shared87 %
Li ANDERSSON The LeftFinland86 % of 2 707 shared87 %
Merja KYLLÖNEN The LeftFinland86 % of 2 926 shared87 %
Manon AUBRY The LeftFrance85 % of 2 897 shared87 %
Marina MESURE The LeftFrance85 % of 2 989 shared87 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Mélissa CAMARA GreensFrance84 % of 2 443 shared77 %
David CORMAND GreensFrance84 % of 2 947 shared77 %
Saskia BRICMONT GreensBelgium83 % of 2 769 shared77 %
Tilly METZ GreensLuxembourg83 % of 2 848 shared77 %
Marie TOUSSAINT GreensFrance83 % of 2 795 shared77 %
Mounir SATOURI GreensFrance83 % of 2 419 shared77 %
Cristina GUARDA GreensItaly83 % of 2 434 shared77 %
Benedetta SCUDERI GreensItaly82 % of 3 007 shared77 %
Vicent MARZÀ IBÁÑEZ GreensSpain82 % of 3 016 shared77 %
Gordan BOSANAC GreensCroatia81 % of 3 010 shared77 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on Agriculture and Rural DevelopmentAGRI CommitteeSubstitute19 Jul 2024now
Committee on the Environment, Climate and Food SafetyENVI CommitteeVice-chair20 Jan 2025now
Committee on FisheriesPECH CommitteeMember19 Jul 2024now
Committee on Public HealthSANT CommitteeSubstitute23 Jan 2025now
Delegation for relations with Australia and New ZealandDANZ DelegationSubstitute19 Sept 2024now
Delegation for Northern cooperation and for relations with Switzerland and Norway and to the EU-Iceland Joint Parliamentary Committee and the European Economic Area (EEA) Joint Parliamentary CommitteeDEEA DelegationMember19 Sept 2024now
Intergroup on Children’s RightsIG10-06 Intergroup / working groupMember19 Feb 2025now
Intergroup on LGBTIQ+IG10-16 Intergroup / working groupMember13 May 2026now
Intergroup on Mental HealthIG10-17 Intergroup / working groupMember5 Feb 2025now
Intergroup on the Welfare and Conservation of AnimalsIG10-27 Intergroup / working groupMember8 Jan 2025now

Show all 13 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
Public health aspects of biotechnology and life sciencesShadow rapporteurSANT27 Apr 2026
Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act)Shadow rapporteur for an opinionENVI20 Apr 2026
Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organsShadow rapporteurSANT27 Mar 2026
Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act)Shadow rapporteurSANT12 Mar 2026
Amending Regulation (EU) No 528/2012 as regards the extension of certain data protection periodsShadow rapporteurENVI12 Mar 2026
Amending Council Directive 98/58/EC and Directive 2009/128/EC of the European Parliament and of the Council as regards the simplification and strengthening of food and feed safety requirements, and repealing Council Directives 82/711/EEC and 85/572/EECShadow rapporteurENVI12 Mar 2026
Amending Regulations (EC) No 999/2001, (EC) No 1829/2003, (EC) No 1831/2003, (EC) No 852/2004, (EC) No 853/2004, (EC) No 396/2005, (EC) No 1099/2009, (EC) No 1107/2009, (EU) No 528/2012, (EU) 2017/625 as regards the simplification and strengthening of food and feed safety requirementsShadow rapporteurENVI12 Mar 2026
Amending Council Directive 98/58/EC and Directive 2009/128/EC of the European Parliament and of the Council as regards the simplification and strengthening of food and feed safety requirements, and repealing Council Directives 82/711/EEC and 85/572/EECShadow rapporteurAGRI3 Mar 2026
Amending Regulations (EC) No 999/2001, (EC) No 1829/2003, (EC) No 1831/2003, (EC) No 852/2004, (EC) No 853/2004, (EC) No 396/2005, (EC) No 1099/2009, (EC) No 1107/2009, (EU) No 528/2012, (EU) 2017/625 as regards the simplification and strengthening of food and feed safety requirementsShadow rapporteurAGRI3 Mar 2026
Amending Regulation (EU) No 1308/2013 as regards the school fruit, vegetables and milk scheme (‘EU school scheme’), sectoral interventions, the creation of a protein sector, requirements for hemp, the possibility for marketing standards for cheese, protein crops and meat, application of additional import duties, rules on the availability of supplies in time of emergencies and severe crisis and securitiesShadow rapporteurAGRI3 Mar 2026

Show all 28 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

16 contributions recorded; 5 on behalf of their group; 21 minutes of speaking time.

Show all 16 recent contributions

Questions and motions, 124

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
14 Sept 2026Exclusion of purchases of Russian sable pelts from EU sanctions E-10-2026-003651Written questionwith 13 co-authorsNot yet answered
11 Sept 2026MOTION FOR A RESOLUTION on the draft Commission regulation amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, etofenprox, fenpropidin, flupyradifurone, hexythiazox, imazalil, spinosad and tebufenozide in or on certain products B-10-2026-0392Motion for a resolutionwith 3 co-authors—
10 Sept 2026EU exports of banned pesticides E-10-2026-003605Written questionwith 35 co-authorsNot yet answered
8 Sept 2026Chatbots directing women with unwanted pregnancies to anti-abortion websites E-10-2026-003539Written questionwith 67 co-authorsNot yet answered
7 Sept 2026Climate change, public health and the world of work: for a directive on maximum working temperatures O-10-2026-000035Oral questionwith 35 co-authorsNot yet answered
2 Sept 2026MOTION FOR A RESOLUTION on the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean GMB151 x DAS-44406-6 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0380Motion for a resolutionwith 3 co-authors—
2 Sept 2026MOTION FOR A RESOLUTION on the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean MON 94313 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0379Motion for a resolutionwith 3 co-authors—
2 Sept 2026MOTION FOR A RESOLUTION on the draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maize MON 87460 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0381Motion for a resolutionwith 3 co-authors—
11 Aug 2026Animal welfare in Uganda in the context of EU development cooperation E-10-2026-003257Written questionwith 1 co-authorNot yet answered
14 Jul 2026Irregularities relating to the validation of the European Citizens’ Initiative ‘Stop Cruelty Stop Slaughter’ E-10-2026-002926Written questionwith 1 co-author15 Sept 2026

Show all 124 questions and motions

Amendments tabled in committee, 93

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
10 Sept 2026Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs CJ64-AM-792139 CJ6424
10 Sept 2026Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs CJ64-AM-792138 CJ6436
20 Jul 2026Amending Directives 2008/98/EC, 2010/75/EU, (EU) 2015/2193 and (EU) 2024/1785 of the European Parliament and of the Council as regards simplification of some requirements and reduction of administrative burden ENVI-AM-790834 ENVI1
15 Jul 2026Amending Regulation (EU) 2023/1542 and Regulation (EU) 2024/1244 as regards simplification of some requirements and reduction of administrative burden ENVI-AM-790846 ENVI1
13 Jul 2026Establishing the conditions for the implementation of the Union support to the Common Agriculture Policy for the period from 2028 to 2034 AGRI-AM-790955 AGRI15
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790936 CJ538
13 Jul 2026Establishing the conditions for the implementation of the Union support to the Common Agriculture Policy for the period from 2028 to 2034 AGRI-AM-790915 AGRI4
13 Jul 2026Establishing the conditions for the implementation of the Union support to the Common Agriculture Policy for the period from 2028 to 2034 AGRI-AM-790899 AGRI21
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790939 CJ5318
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790938 CJ5318

Show all 93 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political groups this term

National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Anja HAZEKAMP”. Member record. memberId 125023. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/125023?page=4&scope=final&vscope=all (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/125023. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/125023?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-125023,
  author = {{EU Parl Watch Research}},
  title = {{Anja HAZEKAMP}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/125023?page=4&scope=final&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/125023?page=4&scope=final&vscope=all},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 125023. Official source: https://www.europarl.europa.eu/meps/en/125023. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}